PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Deborah B. Doroshow, Sheena Bhalla, Mary Beth Beasley, Lynette M. Sholl, Keith M. Kerr, Sacha Gnjatic, Ignacio I. Wistuba, David L. Rimm, Ming‐Sound Tsao, Fred R. Hirsch
Topics & Concepts
MedicineBiomarkerConcordanceBiomarker discoveryOncologyCompanion diagnosticImmune checkpointClinical trialPD-L1CancerDiseaseInternal medicineImmunotherapyBioinformaticsBiologyProteomicsBiochemistryGeneCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsCAR-T cell therapy research